Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EBT Margin: 2018-2021

  • Genmab A's EBT Margin fell 3969.00% to 0.00% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.00%, marking a year-over-year decrease of 1252.00%. This contributed to the annual value of 58.39% for FY2020, which is 511.00% up from last year.
  • Genmab A's EBT Margin amounted to 0.00% in Q2 2021, which was down 100.00% from 38.92% recorded in Q4 2020.
  • In the past 5 years, Genmab A's EBT Margin registered a high of 67.21% during Q4 2019, and its lowest value of -26.63% during Q2 2019.
  • In the last 3 years, Genmab A's EBT Margin had a median value of 38.92% in 2020 and averaged 23.84%.
  • As far as peak fluctuations go, Genmab A's EBT Margin soared by 6,631bps in 2020, and later plummeted by 3,969bps in 2021.
  • Quarterly analysis of 4 years shows Genmab A's EBT Margin stood at 38.52% in 2018, then soared by 2,869bps to 67.21% in 2019, then slumped by 2,829bps to 38.92% in 2020, then plummeted by 3,969bps to 0.00% in 2021.
  • Its last three reported values are 0.00% in Q2 2021, 38.92% for Q4 2020, and 39.69% during Q2 2020.